A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus

Authors

Carisa S De Anda
S. Aubrey Stoch (ORCID: https://orcid.org/0000-0001-5620-7092)
Alex Mann (ORCID: https://orcid.org/0000-0002-3744-4604)
Tian Zhao (ORCID: https://orcid.org/0000-0003-0202-5255)
Mickie Cheng (ORCID: https://orcid.org/0009-0003-5735-1821)
David W. Hilbert (ORCID: https://orcid.org/0000-0003-3257-5880)
Lin Liao (ORCID: https://orcid.org/0000-0002-0278-4879)
Melissa Bevan
Brian M. Maas (ORCID: https://orcid.org/0000-0002-2410-4379)
Andrea Schaeffer
Andrew Catchpole

Institutions

Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
hVIVO (United Kingdom) (GB)

Publication Details

Journal: Pulmonary Therapy
Published: 2025-04-02
DOI: https://doi.org/10.1007/s41030-025-00289-z
Citations: 4
Primary Topic: Respiratory viral infections research
Type: article
Field-Weighted Citation Impact: 5.42

Funders

Merck

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus

Carisa S De Anda, S. Aubrey Stoch, Alex Mann, Tian Zhao et al.

Apr 2, 2025

4 citations

Pulmonary Therapy

Respiratory viral infections research

5.42

article

A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus

Carisa S De Anda, S. Aubrey Stoch, Alex Mann, Tian Zhao, Mickie Cheng, David W. Hilbert, Lin Liao, Melissa Bevan, Brian M. Maas, Andrea Schaeffer, Andrew Catchpole

April 2, 2025article en

4 citations

Abstract

No abstract available for this paper.

Pulmonary TherapyVol. 11(2)

Merck & Co., Inc., Rahway, NJ, USA (United States) (US), hVIVO (United Kingdom) (GB)

Merck

Good health and well-being

Openalex Percentile: Top 5%

Respiratory viral infections research

5.42

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus — Carisa S De Anda, S. Aubrey Stoch, et al. · Pulmonary Therapy (2025) | TGRS Research Map | TGRS